MedPath

A clinical trial to study the efficacy of Rasa chendhuram internal drug for symmetrical multiple joints(Rheumatoid arthritis)

Phase 2
Conditions
Health Condition 1: null- Patients having arthritis of three or more joints pain and swelling in the distal interphalangeal joints morning stiffness patients having RAfactor positive Anti ccp positive and aneamia
Registration Number
CTRI/2017/05/008574
Lead Sponsor
Govt siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age 18-60 Years

Both male and female

Morning stiffness

Pain and swelling in the distal interphalangeal Joints.

RA Factor positive

ANTI CCP POSITIVE

ARTHRITIS OF MORE THAN THREE JOINTS

Exclusion Criteria

Ankylosing Spondylitis

Rheumatic fever

Systemic lupus erythymatosus

Gouty arthritis

History of long term intake of steroids

Osteomyelitis

Pregnant women and lactatin mother

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reducing the pain and morning stiffnessTimepoint: 12 Months
Secondary Outcome Measures
NameTimeMethod
To study the safety profile of the drug before and after treatment.Timepoint: 12 Months
© Copyright 2025. All Rights Reserved by MedPath